| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780100 | Gynecologic Oncology | 2018 | 8 Pages |
Abstract
Our findings highlight the potential of p62 as a new prognostic marker for ovarian cancer patients and p62's associated autophagy pathway may be a promising therapeutic target to prevent metastasis, recurrence and to reverse drug resistance in ovarian cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Jinglu Wang, Cassandra Garbutt, Hangzhan Ma, Peng Gao, Francis J. Hornicek, Quancheng Kan, Huirong Shi, Zhenfeng Duan,